The radiotherapy treatment comes from an electrical machine called a ‘Linear accelerator’ and is directed as a beam to the part of the body that needs to be treated. Treatment is given daily over a period of days or weeks and you may hear people call these treatments ‘fractions’. They are just a fraction of your treatment dose and plan.
Immunotherapy is a biological therapy and type of targeted treatment that boosts the patient’s natural defence, the immune system, and enables it to find and destroy cancer cells found in the body. At Rutherford Cancer Centres, we use several different types of immunotherapy in the treatment of cancer, in order to prevent cells growing and replicating or spreading around the body.
Chemotherapy at the Rutherford takes place in our modern therapy suites, consisting of up to ten treatment areas offering treatment for haematology/oncology patients requiring systemic anti-cancer therapy (SACT) and supportive care in an outpatient setting. The infusion therapy suites are available for patients undergoing treatment for breast, urology, upper and lower gastrointestinal cancers, and both malignant and non-malignant haematology disorders.
Dr Hans van der Voet is a senior consultant clinical oncologist and radiotherapy lead at the James Cook University Hospital in Middlesbrough. He qualified at the University of Amsterdam Medical School in 1989 and started his radiotherapy training at The Netherlands Cancer Institute/Anthony van Leeuwenhoek Hospital in Amsterdam in 1990. He took a year out from training to do a clinical fellowship in bladder cancer at the Christie Hospital in Manchester from 1993. After completion of specialist training at the NCI/AvL in 1995, he returned to the Christie hospital as a senior registrar. In 1997 he took up a position as consultant clinical oncologist in Middlesbrough.
Dr van der Voet specialises and manages a busy practice in urological cancers, lower gastrointestinal cancer including anal cancer and sarcoma. He was instrumental in establishing image guided radiotherapy and subsequently intensity modulated radiotherapy in Middlesbrough. He has a fast experience in the treatment of prostate cancer including stereotactic radiotherapy.
Dr van der Voet also has an interest in providing radiotherapy for the treatment of early Dupuytren’s disease and has been treating patients for this condition since 2013. Dr van der Voet is a member of the Northern Cancer Alliance Radiotherapy Expert Advisory Group.
European Society of Radiotherapy and Oncology
The Royal College of Radiologists
NCA Radiotherapy Expert Advisory Group
Dr Hans van der Voet does not hold a share or financial interest in the Rutherford Cancer Centres or another Proton Partners International company.
Dr Hans van der Voet does not have a share or financial interest in equipment used at the Rutherford Cancer Centres or another Proton Partners International company.
Dr Hans van der Voet does not hold any paid advisory role(s) at the Rutherford Cancer Centres or on behalf of Rutherford Cancer Centres or Proton Partners International.